With the advent of immunotherapy, UCSF physicians are incorporating clinical trials into head and neck cancer patient care and changing the treatment paradigm. Dr. Patrick Ha, chief, Head & Neck Surgical Oncology, discusses this novel approach and opportunities with clinical research.
Related Presenters